Having trouble accessing articles? Reset your cache.

Memantine: Phase IV data

Data from an exploratory, double-blind, European Phase IV trial in 195 patients with mild to moderate PDD or DLB showed that there was no

Read the full 242 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE